Sperzel J, Hamm C, Hain A
Herzzentrum, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany.
Electrophysiology/Device Therapies, Kerckhoff-Klinik GmbH, Benekestr. 2-8, 61231, Bad Nauheim, Germany.
Herz. 2018 Nov;43(7):605-611. doi: 10.1007/s00059-018-4752-9.
Leadless self-contained intracardiac pacemakers were developed with the aim of abolishing the short- and long-term risk of lead- and pocket-related complications associated with transvenous devices. Leadless pacemakers promise minimally invasive procedures, long battery lives, and small amounts of foreign materials in the body. Experiences with the pioneering single-chamber devices have provided reasons for optimism about the future of the leadless concept. In the future, as more patients receive and live longer with implantable devices, the total risk of procedure- and lead-related complications is expected to increase, adding a sense of urgency to the need for leadless alternatives to transvenous pacemakers. This review surveys the performance of currently available leadless pacemakers as well as emerging new innovative adaptations and applications of the leadless concept.
无导线独立式心内起搏器的研发旨在消除与经静脉装置相关的导线和囊袋相关并发症的短期和长期风险。无导线起搏器有望实现微创手术、长电池寿命以及体内异物量少。首批单腔装置的使用经验为无导线概念的未来发展带来了乐观理由。未来，随着越来越多的患者接受植入式装置并存活更长时间，手术和导线相关并发症的总体风险预计会增加，这使得寻找经静脉起搏器的无导线替代方案变得更加紧迫。本综述调查了目前可用的无导线起搏器的性能，以及无导线概念的新出现的创新适应和应用。
